Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs PARMAX PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA PARMAX PHARMA SUN PHARMA/
PARMAX PHARMA
 
P/E (TTM) x 38.9 -4.8 - View Chart
P/BV x 6.8 230.5 3.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 SUN PHARMA   PARMAX PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-24
PARMAX PHARMA
Mar-24
SUN PHARMA/
PARMAX PHARMA
5-Yr Chart
Click to enlarge
High Rs1,63437 4,467.1%   
Low Rs92324 3,815.3%   
Sales per share (Unadj.) Rs202.121.5 938.0%  
Earnings per share (Unadj.) Rs40.2-11.3 -354.9%  
Cash flow per share (Unadj.) Rs50.9-8.0 -637.9%  
Dividends per share (Unadj.) Rs13.500-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs265.40.1 190,604.3%  
Shares outstanding (eoy) m2,399.345.10 47,045.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.31.4 448.5%   
Avg P/E ratio x31.8-2.7 -1,185.4%  
P/CF ratio (eoy) x25.1-3.8 -659.5%  
Price / Book Value ratio x4.8218.3 2.2%  
Dividend payout %33.60-   
Avg Mkt Cap Rs m3,067,070155 1,979,233.6%   
No. of employees `000NANA-   
Total wages/salary Rs m94,29129 322,802.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m484,969110 441,281.6%  
Other income Rs m16,2820 3,392,166.7%   
Total revenues Rs m501,251110 454,113.9%   
Gross profit Rs m122,548-34 -363,750.7%  
Depreciation Rs m25,56617 149,336.4%   
Interest Rs m2,3856 38,277.7%   
Profit before tax Rs m110,879-57 -196,037.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14,3951 1,170,284.6%   
Profit after tax Rs m96,484-58 -166,956.9%  
Gross profit margin %25.3-30.7 -82.4%  
Effective tax rate %13.0-2.2 -597.5%   
Net profit margin %19.9-52.6 -37.8%  
BALANCE SHEET DATA
Current assets Rs m434,33158 752,740.2%   
Current liabilities Rs m169,83892 184,365.7%   
Net working cap to sales %54.5-31.3 -174.1%  
Current ratio x2.60.6 408.3%  
Inventory Days Days1356 2,198.7%  
Debtors Days Days8560,312,902 0.0%  
Net fixed assets Rs m378,84396 396,278.8%   
Share capital Rs m2,39945 5,390.5%   
"Free" reserves Rs m634,268-44 -1,448,100.9%   
Net worth Rs m636,6681 89,671,478.9%   
Long term debt Rs m1359 22.5%   
Total assets Rs m813,592153 530,684.4%  
Interest coverage x47.5-8.1 -587.9%   
Debt to equity ratio x083.2 0.0%  
Sales to assets ratio x0.60.7 83.2%   
Return on assets %12.2-33.6 -36.1%  
Return on equity %15.2-8,139.1 -0.2%  
Return on capital %17.8-84.2 -21.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m142,6830-   
Fx outflow Rs m62,9320-   
Net fx Rs m79,7520-   
CASH FLOW
From Operations Rs m121,350-2 -6,386,831.6%  
From Investments Rs m-6,902-16 43,490.9%  
From Financial Activity Rs m-67,10214 -470,228.5%  
Net Cashflow Rs m46,619-4 -1,331,977.1%  

Share Holding

Indian Promoters % 54.5 30.8 176.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 0.0 -  
FIIs % 18.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 69.2 65.8%  
Shareholders   657,317 2,245 29,279.2%  
Pledged promoter(s) holding % 0.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    ZYDUS LIFESCIENCES    


More on Sun Pharma vs PARMAX PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs PARMAX PHARMA Share Price Performance

Period Sun Pharma PARMAX PHARMA S&P BSE HEALTHCARE
1-Day 0.55% -5.00% 0.97%
1-Month -2.83% -3.64% 1.29%
1-Year 51.72% 40.29% 46.30%
3-Year CAGR 32.21% 2.91% 19.65%
5-Year CAGR 31.55% 18.13% 26.13%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the PARMAX PHARMA share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of PARMAX PHARMA the stake stands at 30.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of PARMAX PHARMA.

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 13.5 per share. This amounted to a Dividend Payout ratio of 33.6%.

PARMAX PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of PARMAX PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.